Signaling pathways
-
BA6018 YQ128Summary: YQ128 is a potent, selective second-generation inhibitor. -
BA6019 PivekimabSummary: Pivekimab is available for the study of Bastoid Plasmacytoid Dendritic Cell Neoplasms (BPDCN). -
BA6020 AngolineSummary: Angoline is a potent and selective inhibitor of signaling pathways. -
BA6021 SonelokimabSummary: Sonelokimab (ALX0761; M1095) is a trivalent nanobody composed of monovalent camel-derived nanobodies specific for human interleukin (IL)-17A, IL-17F and human serum albumin VHH. -
BA6023 OrdesekimabSummary: Ordesekimab (AMG714; PRV-015) is a human IgG1κ anti-monoclonal antibody. -
BA6024 NepetinSummary: Nepetin is a natural flavonoid isolated from HBK with potent anti-inflammatory activity. -
BA6025 RilonaceptSummary: Rilonacept (Arcalyst) is a dimeric fusion protein that is an interleukin 1 inhibitor. -
BA6026 SP4206Summary: SP4206 is an interaction inhibitor. -
BA6027 LokivetmabSummary: An anticanine monoclonal antibody. -
BA6028 HydrocotarnineSummary: Hydrocotarnine is an inhibitor that leads to inflammatory vesicle-mediated secretion in colitis.

